Alloy Women's Health

We're #hiring a new Finance Operations Manager in United States. Apply today or share this post with your network.

We recently shared that we raised $16 million in Series A funding to continue our work transforming menopause care. This investment will help us expand our platform, enhance our offerings for healthcare providers, and deliver more personalized care to women navigating this stage of life. A huge thank you to our incredible investors—Kairos HQ, PACE Healthcare Capital, Emmeline Ventures, and Amboy Street Ventures—for their trust and belief in our mission. This is just the beginning! We’re so grateful to be here and are excited about the future of menopause care. Thanks Emma Hinchliffe and Fortune sharing the news and our story! https://lnkd.in/envj2iBB

We successfully closed a $16 million Series A funding round. We’re especially proud to share this news on Women’s Entrepreneurship Day as we continue our journey to drive change in women’s health and transform menopause care. Read more about it in a letter from our Co-Founders, Anne Fulenwider and Monica Molenaar.

We're #hiring a new Vice President of Marketing in United States. Apply today or share this post with your network.

How did Anne Fulenwider go from being a magazine editor in chief to the co-Founder of a menopause healthcare company? Learn all about her journey and how the skills she learned in publishing made her perfectly poised to take on the role of entrepreneur on the Second Life podcast! Listen on Apple Podcasts and Spotify. https://lnkd.in/eunxAjff

We believe in the power of conversation to transform women’s health. Recently, we hosted an event focused on estrogen and menopause to celebrate the new edition of Dr. Avrum Bluming and Dr. Carol Tavris’s book, Estrogen Matters. Dr. Bluming and our chief Medical Advisor, Dr. Sharon Malone, sat down for a conversation moderated by our host, Tamsen Fadal, to talk about menopause care, estrogen, and the importance of continuing the conversation. This week’s piece in Flow Space perfectly sums up the event. We love seeing menopause and estrogen getting the coverage they deserve! Together, let’s advocate for informed choices and empower women to take control of their health journeys. https://lnkd.in/ecnMHxxH

Happy Menopause Awareness Month from all of us at Alloy! In honor of Menopause Awareness Month, we’ve partnered with Tiny Miracles (B Corp). Every new Alloy order placed in October will come in a unique, hand-stitched pouch crafted by a menopausal woman from a vulnerable community in Mumbai, India. Tiny Miracles gives women from these communities the opportunity to earn life-changing income as well as access to a safe space to unpack their menopausal journeys, break stigmas, and receive mental health support. Learn more about our partnership here: myalloy.com/tinymiracles

Inspired by her own #healthcare journey, Monica Molenaar, Co-Founder and Co-CEO at Alloy Women's Health, is making real change for women when it comes to the workplace and their health. Hear her story and some key takeaways on being a leader, mother, and a #womaninbusiness.♀https://bit.ly/3MJXYBX #PasstheMic #leadership #femaleempowerment #workplacehealth #womenshealth #CEOadvice #business #entrepreneur

We’re so proud to share that our Co-Founder and Co-CEO Anne Fulenwider and Chief Medical Advisor Dr. Sharon Malone are on this year’s Forbes 50 Over 50 list! And, they’re in pretty incredible company. At Alloy Women's Health, we firmly believe that this phase of life can be one of the best. With age comes wisdom, confidence, and perspective, which can lead to all sorts of incredible things, including launching a company that helps other women be their best selves. https://lnkd.in/gkEepw8

The results are IN! Alloy contracted an independent expert dermatologist investigator to conduct a double-blind, three-armed, placebo-controlled study of the efficacy and safety of M4 Estriol Face Cream and estradiol with M4 cream base. Here’s what we found:In just 12 weeks, statistically significant improvements (as compared to a placebo) with M4 include: • 88% improvement in skin elasticity • 70% improvement in hydration • 57% improvement in skin appearance and texture • 48% improvement in radiance • 68% improvement in overall skin health And, the study found: • NO statistically significant change in estriol levels in the blood from baseline to week 12 • NO evidence of inflammation or damage to the skin barrier • NO tolerability issues. M4 does not cause dryness, peeling, stinging, or itching More about the study: Alloy Women’s Health commissioned Dermatology Consulting Services, PLLC, and Allendale Institutional Review Board (AIRB) to conduct a clinical study assessing the facial anti-aging efficacy of topical estriol and estradiol. The study took place over 12 weeks, and was randomized, double-blind, and vehicle-controlled. Read the full study here: https://lnkd.in/eneTWnuq #AlloyWomensHealth #AlloyM4